van der Pal HJH - Search Results

1

Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS-LATER study.

Claessens JJM, Penson A, Bronkhorst EM, Kremer LCM, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Tissing WJE, van der Pal HJH, Blijlevens NMA, van den Heuvel-Eibrink MM, Versluys AB, Bresters D, Ronckers CM, Walraven I, Beerendonk CCM, Loonen JJ; Dutch LATER study group. Claessens JJM, et al. Among authors: van der pal hjh. Cancer. 2024 Mar 15;130(6):995-1004. doi: 10.1002/cncr.35119. Epub 2023 Dec 6. Cancer. 2024. PMID: 38055238

2

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voûte PA. Kremer LC, et al. Ann Oncol. 2002 Jun;13(6):819-29. doi: 10.1093/annonc/mdf167. Ann Oncol. 2002. PMID: 12123328 Free article. Review.

3

Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.

van Dalen EC, van der Pal HJ, Bakker PJ, Caron HN, Kremer LC. van Dalen EC, et al. Eur J Cancer. 2004 Mar;40(5):643-52. doi: 10.1016/j.ejca.2003.12.006. Eur J Cancer. 2004. PMID: 15010064 Review.

4

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.

van der Pal HJ, van Dalen EC, Kremer LC, Bakker PJ, van Leeuwen FE. van der Pal HJ, et al. Cancer Treat Rev. 2005 May;31(3):173-85. doi: 10.1016/j.ctrv.2005.03.008. Cancer Treat Rev. 2005. PMID: 15896910 Review.

5

Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Eur J Cancer. 2006 Oct;42(15):2549-53. doi: 10.1016/j.ejca.2006.04.014. Epub 2006 Aug 17. Eur J Cancer. 2006. PMID: 16919450

6

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Eur J Cancer. 2006 Dec;42(18):3191-8. doi: 10.1016/j.ejca.2006.08.005. Epub 2006 Sep 20. Eur J Cancer. 2006. PMID: 16987655

7

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. van Dalen EC, et al. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005008. doi: 10.1002/14651858.CD005008.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054232 Updated. Review.

8

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE. Geenen MM, et al. JAMA. 2007 Jun 27;297(24):2705-15. doi: 10.1001/jama.297.24.2705. JAMA. 2007. PMID: 17595271

9

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. van Dalen EC, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005008. doi: 10.1002/14651858.CD005008.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821337 Updated. Review.

10

Evaluation of late adverse events in long-term wilms' tumor survivors.

van Dijk IW, Oldenburger F, Cardous-Ubbink MC, Geenen MM, Heinen RC, de Kraker J, van Leeuwen FE, van der Pal HJ, Caron HN, Koning CC, Kremer LC. van Dijk IW, et al. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):370-8. doi: 10.1016/j.ijrobp.2009.08.016. Epub 2010 Feb 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 20137867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page